David Oxley in

David Oxley

Login to view DISC.
CEO, Vaccinogen | OncoVAX®— Immunotherapy to Prevent Stage II Colon Cancer Recurrence at Vaccinogen
📍 United States

David Oxley is the CEO of Vaccinogen, spearheading the global strategy for OncoVAX®, a personalized immunotherapy for Stage II colon cancer. An alumnus of Johns Hopkins University with over 25 years in biotechnology and life sciences, his expertise spans capital markets, cross-border licensing, and navigating FDA regulatory pathways for novel therapies.

He holds Series 7 and 63 securities licenses, an uncommon qualification for a biotech CEO that highlights his distinct expertise in corporate finance and investor relations.

Read the full overview →
Experience
8 Years
Current Role
CEO, Vaccinogen | OncoVAX®— Immunotherapy to Prevent Stage II Colon Cancer Recurrence
Job Level
Leadership
Location
United States
Personality Overview

How David shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics David cares about

Cancer Immunotherapy
He is leading the development of OncoVAX® to prevent Stage II colon cancer recurrence, focusing on the post-surgical curative window to train the immune system.
Biotech Capital Markets
His background includes Series 7/63 licenses and experience with pre-IPO financing and readiness for NASDAQ/NYSE listings, demonstrating deep knowledge of biotech fundraising.
+5 more topics Login to view topics
Career

Work history

11-2025
CEO, Vaccinogen | OncoVAX®— Immunotherapy to Prevent Stage II Colon Cancer Recurrence
Vaccinogen
6-2025
Member Board of Directors
Caladrix
2-2023 - 11-2025
Chief Business Officer
BIORCHESTRA Co., Ltd.
8-2021 - 1-2023
President International
Exopharm Ltd
8-2017 - 9-2022
Sr. Vice President, Business Development & Licensing
Mesoblast Limited
In the press

Media appearances

Vaccinogen Lands $80M. Featured in VC News Daily
See now
Education
1996 - 1998
MA
The Johns Hopkins University
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

JM
Joan Moore
Office Administrator
Harmony Dental
 Johann Sparfel
Johann Sparfel
Partner
AT.scale
 Debby Wright
Debby Wright
President
Four Seasons Dental Spa
 Allyson Myers
Allyson Myers
Vice President, Sales & Marketing
Lake Champlain Chocolates | Certified B Corp
Unlock the full playbookSee exactly how to sell to David. Free, 10 seconds.